Badugu S, Dhyani K, Thakur M, Muniyappa K
Elife. 2024; 13.
PMID: 39630591
PMC: 11616998.
DOI: 10.7554/eLife.96933.
Barda N, Ayiku P, Bar-On A, Movshovitz S, Listovsky T
Int J Mol Sci. 2024; 25(21).
PMID: 39519037
PMC: 11545987.
DOI: 10.3390/ijms252111485.
Boucher M, Banerjee S, Joshi M, Wei A, Huang M, Lei S
bioRxiv. 2024; .
PMID: 39484549
PMC: 11526942.
DOI: 10.1101/2024.10.22.619677.
Dash R, Arianna G, Patel S, Rizzo A, Harrahill N, Korzhnev D
Structure. 2024; 32(11):2134-2146.e3.
PMID: 39366370
PMC: 11631137.
DOI: 10.1016/j.str.2024.09.007.
Biller M, Kabir S, Boado C, Nipper S, Saffa A, Tal A
Cell Cycle. 2024; 23(4):339-352.
PMID: 38557443
PMC: 11174130.
DOI: 10.1080/15384101.2024.2333227.
AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.
Li L, Jiang P, Hu W, Zou F, Li M, Rao T
J Transl Med. 2024; 22(1):295.
PMID: 38515112
PMC: 10956193.
DOI: 10.1186/s12967-024-05099-6.
The Immunohistochemical Expression of REV-7 in Various Human Cancer Pathology Specimens: A Systematic Review.
Spinos T, Goutas D, Driva T, Zografos E, Gakiopoulou C, Agrogiannis G
Cureus. 2024; 16(1):e52542.
PMID: 38371007
PMC: 10874486.
DOI: 10.7759/cureus.52542.
Predictive tissue markers in testicular germ cell tumors: Immunohistochemical expression of MLH1 and REV-7 proteins.
Spinos T, Zografos E, Koutsoukos K, Zagouri F, Kosmas C, Driva T
Int Urol Nephrol. 2024; 56(6):1887-1898.
PMID: 38285100
PMC: 11090952.
DOI: 10.1007/s11255-023-03933-2.
REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.
Tamaki A, Kato T, Sakurai Y, Sato K, Adachi K, Tadehara M
Cancer Sci. 2023; 115(2):660-671.
PMID: 38130032
PMC: 10859597.
DOI: 10.1111/cas.16044.
The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma.
Liu Z, Wang S, Yu K, Chen K, Zhao L, Zhang J
J Transl Med. 2023; 21(1):863.
PMID: 38017538
PMC: 10685699.
DOI: 10.1186/s12967-023-04740-0.
Mad2B forms a complex with Cdc20, Cdc27, Rev3 and Rev1 in response to cisplatin-induced DNA damage.
Kim J, Patel R
Korean J Physiol Pharmacol. 2023; 27(5):427-436.
PMID: 37641805
PMC: 10466067.
DOI: 10.4196/kjpp.2023.27.5.427.
Implications of Translesion DNA Synthesis Polymerases on Genomic Stability and Human Health.
Venkadakrishnan J, Lahane G, Dhar A, Xiao W, Bhat K, Pandita T
Mol Cell Biol. 2023; 43(8):401-425.
PMID: 37439479
PMC: 10448981.
DOI: 10.1080/10985549.2023.2224199.
REV7 in Cancer Biology and Management.
Murakumo Y, Sakurai Y, Kato T, Hashimoto H, Ichinoe M
Cancers (Basel). 2023; 15(6).
PMID: 36980607
PMC: 10046837.
DOI: 10.3390/cancers15061721.
MAD2B Blunts Chronic Unpredictable Stress and Corticosterone Stimulation-Induced Depression-Like Behaviors in Mice.
Wang X, Miao C, Su Y, Zhang C, Meng X
Int J Neuropsychopharmacol. 2022; 26(2):137-148.
PMID: 36573299
PMC: 9926055.
DOI: 10.1093/ijnp/pyac083.
CCAR2 functions downstream of the Shieldin complex to promote double-strand break end-joining.
Iyer D, Harada N, Clairmont C, Jiang L, Martignetti D, Nguyen H
Proc Natl Acad Sci U S A. 2022; 119(49):e2214935119.
PMID: 36442094
PMC: 9894118.
DOI: 10.1073/pnas.2214935119.
MAD2L2 promotes replication fork protection and recovery in a shieldin-independent and REV3L-dependent manner.
Paniagua I, Tayeh Z, Falcone M, Hernandez Perez S, Cerutti A, Jacobs J
Nat Commun. 2022; 13(1):5167.
PMID: 36075897
PMC: 9458726.
DOI: 10.1038/s41467-022-32861-5.
CHAMP1 binds to REV7/FANCV and promotes homologous recombination repair.
Li F, Sarangi P, Iyer D, Feng H, Moreau L, Nguyen H
Cell Rep. 2022; 40(9):111297.
PMID: 36044844
PMC: 9472291.
DOI: 10.1016/j.celrep.2022.111297.
Functions and Regulation of Meiotic HORMA-Domain Proteins.
Prince J, Martinez-Perez E
Genes (Basel). 2022; 13(5).
PMID: 35627161
PMC: 9141381.
DOI: 10.3390/genes13050777.
Disrupting the MAD2L2-Rev1 Complex Enhances Cell Death upon DNA Damage.
Pernicone N, Elias M, Onn I, Tobi D, Listovsky T
Molecules. 2022; 27(3).
PMID: 35163901
PMC: 8838411.
DOI: 10.3390/molecules27030636.
The (Lack of) DNA Double-Strand Break Repair Pathway Choice During V(D)J Recombination.
Libri A, Marton T, Deriano L
Front Genet. 2022; 12:823943.
PMID: 35082840
PMC: 8785701.
DOI: 10.3389/fgene.2021.823943.